187 related articles for article (PubMed ID: 32295932)
21. [Efficacy of triple versus quadruple furazolidone-based eradication regimens for Helicobacter pylori infection].
Lü Z; Xie Y; Lü N; Zhou H; Liu Z; Zhu X; Chen Y; He X; Liu D; Ma J
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):572-5. PubMed ID: 24762683
[TBL] [Abstract][Full Text] [Related]
22. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China: an open-label, randomized clinical trial.
Chen L; He J; Wang L; Ge Q; Chu H; Chen Y; Chen X; Long Y; Deng Y; He H; Li A; Chen S
Clin Exp Med; 2018 Nov; 18(4):569-576. PubMed ID: 29876770
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Kahramanoğlu Aksoy E; Pirinçci Sapmaz F; Göktaş Z; Uzman M; Nazlıgül Y
Med Princ Pract; 2017; 26(6):523-529. PubMed ID: 29131124
[TBL] [Abstract][Full Text] [Related]
24. Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease.
Malekzadeh R; Ansari R; Vahedi H; Siavoshi F; Alizadeh BZ; Eshraghian MR; Vakili A; Saghari M; Massarrat S
Aliment Pharmacol Ther; 2000 Mar; 14(3):299-303. PubMed ID: 10735922
[TBL] [Abstract][Full Text] [Related]
25. Fourteen- vs seven-day bismuth-based quadruple therapy for second-line Helicobacter pylori eradication.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Jul; 21(26):8132-9. PubMed ID: 26185386
[TBL] [Abstract][Full Text] [Related]
26. [Effect of furazolidone quadruple regimen plus dental plaque removal procedures as rescue treatment of refractory Helicobacter pylori infection].
Gao W; Hu FL; Wang XM
Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):836-9. PubMed ID: 21600165
[TBL] [Abstract][Full Text] [Related]
27. Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Chen Q; Zhang W; Fu Q; Liang X; Liu W; Xiao S; Lu H
Am J Gastroenterol; 2016 Dec; 111(12):1736-1742. PubMed ID: 27670603
[TBL] [Abstract][Full Text] [Related]
28. Annual eradication rate of bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: A 15-year prospective study at a tertiary hospital in Korea.
Yoon K; Kim N; Lee JW; Yoon H; Shin CM; Park YS; Lee DH
Helicobacter; 2020 Jun; 25(3):e12685. PubMed ID: 32141173
[TBL] [Abstract][Full Text] [Related]
29. [Influence of two kinds of probiotics combined with bismuth quadruple therapy for
Zhu XY; Du J; Zhao WJ; Wu J; Zhao LW; Meng X; Yang L; Jiao L; Ma H
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(28):2246-2249. PubMed ID: 30078279
[No Abstract] [Full Text] [Related]
30. [Tetracycline and metronidazole based quadruple regimen as first line treatment for penicillin allergic patients with
Gao W; Zheng SH; Cheng H; Wang C; Li YX; Xu Y; Hu FL
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1536-1540. PubMed ID: 31154718
[No Abstract] [Full Text] [Related]
31. Esomeprazole, minocycline, metronidazole and bismuth as first-line and second-line regimens for Helicobacter pylori eradication.
Song ZQ; Zhou LY
J Dig Dis; 2016 Apr; 17(4):260-7. PubMed ID: 26946480
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of modified tetracycline dosing in a quadruple therapy for
Sun YC; Zhu MJ; Chen XQ; Yue L; Zhao YR; Wang XJ; Kim JJ; Du Q; Hu WL
World J Gastroenterol; 2023 Jun; 29(22):3508-3518. PubMed ID: 37389237
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of quadruple therapy with pantoprazole, bismuth, tetracycline and metronidazole as rescue treatment for Helicobacter pylori infection.
Boixeda D; Bermejo F; Martín-De-Argila C; López-Sanromán A; Defarges V; Hernández-Ranz F; Milicua JM; García-Plaza A
Aliment Pharmacol Ther; 2002 Aug; 16(8):1457-60. PubMed ID: 12182745
[TBL] [Abstract][Full Text] [Related]
34. Ten-day Quadruple therapy comprising proton-pump inhibitor, bismuth, tetracycline, and levofloxacin achieves a high eradication rate for Helicobacter pylori infection after failure of sequential therapy.
Hsu PI; Chen WC; Tsay FW; Shih CA; Kao SS; Wang HM; Yu HC; Lai KH; Tseng HH; Peng NJ; Chen A; Kuo CH; Wu DC;
Helicobacter; 2014 Feb; 19(1):74-9. PubMed ID: 24033865
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of bismuth-based quadruple therapy for eradication of Helicobacter pylori infection based on previous antibiotic exposure: A large-scale prospective, single-center clinical trial in China.
Zhou JJ; Shi X; Zheng SP; Tang D; Cai T; Yao Y; Wang F
Helicobacter; 2020 Dec; 25(6):e12755. PubMed ID: 32914914
[TBL] [Abstract][Full Text] [Related]
36. The "three-in-one" formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.
Zagari RM; Romiti A; Ierardi E; Gravina AG; Panarese A; Grande G; Savarino E; Maconi G; Stasi E; Eusebi LH; Farinati F; Conigliaro R; Bazzoli F; Romano M
Helicobacter; 2018 Aug; 23(4):e12502. PubMed ID: 29924430
[TBL] [Abstract][Full Text] [Related]
37. Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
Pan J; Shi Z; Lin D; Yang N; Meng F; Lin L; Jin Z; Zhou Q; Wu J; Zhang J; Li Y
Front Med; 2020 Feb; 14(1):43-50. PubMed ID: 31907860
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial.
Frota LC; da Cunha Mdo P; Luz CR; de Araujo-Filho AH; Frota LA; Braga LL
Arq Gastroenterol; 2005; 42(2):111-5. PubMed ID: 16127567
[TBL] [Abstract][Full Text] [Related]
39. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
40. New bismuth-containing quadruple therapy in patients infected with Helicobacter pylori: A first Italian experience in clinical practice.
Tursi A; Di Mario F; Franceschi M; De Bastiani R; Elisei W; Baldassarre G; Ferronato A; Grillo S; Landi S; Zamparella M; De Polo M; Boscariolo L; Picchio M
Helicobacter; 2017 Jun; 22(3):. PubMed ID: 28125857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
